Western University

Scholarship@Western
Neuroscience Institute Publications

Western Institute for Neuroscience

1-1-2022

Factors Associated with The Incidence of Coronary Heart Disease
in The Mashad: A Cohort Study
Fatemeh Sadabadi
Mashhad University of Medical Sciences

Mohsen Moohebati
Cardiovascular Research Center

Alireza Heidari-Bakavoli
Cardiovascular Research Center

Sousan Darroudi
Mashhad University of Medical Sciences

Shahin Nazarpour
Mashhad University of Medical Sciences

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/neurosci_inst_pubs

Citation of this paper:
Sadabadi, Fatemeh; Moohebati, Mohsen; Heidari-Bakavoli, Alireza; Darroudi, Sousan; Nazarpour, Shahin;
Khorrami Mohebbseraj, Mohammad Sadegh; Asadi, Zahra; Esmaeily, Habibollah; Ghazizadeh, Hamideh;
Barati, Elham; Gonabadi, Najmeh Malekzadeh; Samadi, Sara; Tayefi, Maryam; Izadi Mood, Zahra;
Azarpazhooh, Mahmoud Reza; Heidari-Bakavoli, Sahar; Hoori, Tara; Bahramizadeh Sajjadi, Ramin; Ferns,
Gordon A.; Ghayour-Mobarhan, Majid; and Heidarian Miri, Hamid, "Factors Associated with The Incidence
of Coronary Heart Disease in The Mashad: A Cohort Study" (2022). Neuroscience Institute Publications.
64.
https://ir.lib.uwo.ca/neurosci_inst_pubs/64

Authors
Fatemeh Sadabadi, Mohsen Moohebati, Alireza Heidari-Bakavoli, Sousan Darroudi, Shahin Nazarpour,
Mohammad Sadegh Khorrami Mohebbseraj, Zahra Asadi, Habibollah Esmaeily, Hamideh Ghazizadeh,
Elham Barati, Najmeh Malekzadeh Gonabadi, Sara Samadi, Maryam Tayefi, Zahra Izadi Mood, Mahmoud
Reza Azarpazhooh, Sahar Heidari-Bakavoli, Tara Hoori, Ramin Bahramizadeh Sajjadi, Gordon A. Ferns,
Majid Ghayour-Mobarhan, and Hamid Heidarian Miri

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/neurosci_inst_pubs/64

Journal of Biostatistics and Epidemiology
J Biostat Epidemiol. 2022;8(2):160-169

Original Article
Factors Associated with The Incidence of Coronary Heart Disease in The Mashad:
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ABSTRACT
Introduction: Coronary heart disease (CHD) is the leading cause of morbidity and mortality globally, and
specially in Iran. An accurate assessment of the incidence of coronary heart disease (CHD) is very important
for public health. In current study we aimed to investigate the incidence of CHD and importance of several
classical modifiable and un-modifiable risk factors for CHD among an urban population in eastern Iran after
6 years follow-up.
Methods: The population of MASHAD cohort study were followed up for 6 years, every 3 years initially by
phone and those who reported symptoms of cardiovascular disease (CVD) were asked to attend for a cardiac
examination. An estimate of the incidence of CHD was determined with 95% confidence interval (95% CI) and
multiple logistic regression analysis was performed to assess the association of several baseline characteristics
with the incidence of a CHD event. Evaluation of goodness-of-fit was undertaken using ROC analysis. CHD
cases were divided into four different categories: stable angina, unstable angina pectoris, myocardial infarction
and sudden cardiac death.
Results: In the six years of follow-up of the Mashhad study participants, the incidence density of CHD events
in men and women in 1000 person-year with 95% confidence intervals were 19.20 (8.10-30.30) and 11.60
(7.30-15.90), respectively. The areas under ROC curve (AUC), based on multiple logistic regression model of
CHD outcome, was determined to be 0.783.
Conclusion: Our findings indicated that the incidence rate of coronary heart diseases in MASHAD cohort
study increases with age, and our final model was able to predict approximately 78% of CHD events in this
Iranian population.
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Introduction
Coronary heart disease (CHD) is the leading
cause of death and disability in developed
countries,1 accounting for approximately onethird of all deaths over the age of 35 years.
However, there has been a sustained reduction
in CHD mortality rates over recent years, in
major part due to improvements in its clinical
management.2, 3
CHD is usually due to partial or complete
occlusion of one or more coronary arteries.
This is often a consequence of atheroma,
consisting of lipid-laden cells, extracellular
matrix and extracellular lipid, accumulating in
the artery wall. Complete occlusion leads to a
myocardial infarction, and is often preceded by
inflammation and rupture of an atheromatous
plaque and the formation of an occlusive
thrombus. Partial occlusion may lead to angina.4
CHD risk factors may be broadly categorized
as modifiable and non-modifiable. The latter
include: age, sex, and genetic factors such as
familial hypercholesterolemia that are associated
with a family history of premature CHD.
Modifiable risk factors include: hypertension,
cigarette smoking, dyslipidemia (raised serum
low density lipoprotein and triglycerides, or
low high density lipoprotein), impaired glucose
tolerance including diabetes mellitus (DM),
physical inactivity, and obesity5-7 Several
independent risk factors for CHD have been
identified.8 The IN TERHEART study suggests
that a large proportion of the risk of a first MI is
related to 9 potentially modifiable risk factors
(smoking, dyslipidemia, hypertension (HTN),
DM, abdominal obesity, inadequate physical
activity, insufficient daily consumption of fruit
and vegetable, excess alcohol consumption and
the psychosocial factors), and these appear to
be consistent in both sex, across geographic
regions, and by ethnic group.9, 10

There is a high prevalence of CHD risk factors
among Iranian adults,10 and CHD remains an
important public health burden in Iran, with
a high prevalence and attributable mortality
rate.11 There are few reports regarding the
incidence rate of cardiovascular diseases
(CVD) in Middle Eastern countries, while most
studies have just reported its prevalence.12 Only
two studies have been carried out in Tehran and
Isfahan to determine the incidence rate of CVD
in Iran, and no other study has been found in
eastern Iran so far.12-14
Obtaining information about epidemiology of
CHD is essential to inform and improve policy
making for its prevention. In this study we
aimed to investigate the importance of several
classical, modifiable and un-modifiable risk
factors for CHD in the Mashhad stroke and
heart atherosclerotic disorder study (MASHAD
cohort study), recruited from an Iranian
population from northeastern Iran, assessed
after 6 years follow-up.
Materials and Methods
Baseline
assessment
follow-up
identification of incident CHD
Study design

and

The MASHAD study is a prospective
population-based cohort study.15 The study
recruitment began in 2007 and individuals
were followed up every 3 years. The study
concluded in 2020. Several CHD risk factors
were assessed at baseline as determined
from medical history, physical examination,
questionnaires and laboratory tests to evaluate
notable risk factors.
Participants
A stratified (age, sex, municipality) cluster
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random sample of men and women were
drawn from three different regions in Mashhad.
Mashhad is religious city and the second
most populous and large city in Iran, located
in Khorasan Razavi province. A total of
9704 subjects, aged between 35 and 65 were
enrolled. The subjects who had CHD, stroke
and peripheral arterial disease, were excluded
from project at baseline. Written informed
consent was obtained from all subjects. The
project was approved by the MUMS Ethics
Committee.
Setting
All the participants were assessed at least
twice at follow up in 2011 and 2014 by phone
at a pre-agreed time and date. Data collection
was performed using cardiovascular standard
questionnaires. Subsequently the participants
who claimed to have a CHD event, or had
a history of hospitalization for CHD, were
invited for further investigation in 2015. They
were instructed to attend an arranged medical
follow-up with a cardiologist and provide all
their related medical documents.
Variables and measurement
During the follow-up session, blood samples
were obtained between 8 and 10 a.m. after 12hour overnight fast and serum harvested for the
measurement of, serum total cholesterol (TC),
low-density lipoprotein cholesterol (LDL-C),
triglycerides (TGs), high-density lipoprotein
cholesterol (HDL-C), fasting blood glucose
(FBG) and high sensitivity C-reactive protein
(Hs-CRP) concentrations. The mentioned
biochemical parameters were measured
by routine methods using an auto-analyzer
(BT3000), and routine enzymatic methods,

using Pars Azmoon kits (mg/ dl).
Blood pressure measurement were undertaken
using the right arm after a 10-min rest with
subjects in a seated position using a mercury
sphygmomanometer; blood pressure was
measured twice, separated by a 3-minute
interval; the mean of 2 separated recordings
was recorded. Anthropometric parameters for
all participants including height, weight, waist
circumference and hip circumference were
measured according to standard protocol which
described, recently. The body mass index
(BMI) was calculated by dividing weight to
height squared (m2).15 Afterwards, a 12-lead
electrocardiogram (ECG) was undertaken
for each participant reported to have CHD
then examined by a cardiologist. Possible
cardiovascular disease was diagnosed using
ECG, clinical findings, and medical history.
If necessary, additional medical examinations
were performed for the subjects and also tests
such as stress echocardiography, radioisotope,
angiography, computed tomography (CT)
angiography and exercise tolerance test (ETT)
and review of available medical records were
performed. Finally, cases with a possible CHD
event were reviewed by a panel of specialists
who agreed a definite diagnosis. Patients
with established CHD were divided into four
categories: stable angina, unstable angina
pectoris, myocardial infarction, and sudden
cardiac death, confirmed by death registration
system of the Mashhad health center and
registered according to the International
Classification of Diseases-10 (ICD-10, versions
2010).16
Statistical methods
Stata software, (Stata 14, 2015, StataCorp
LP, TX, USA) and SPSS version 16 were
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used for all statistical analyses. Variables that
were normally distributed were expressed
as means ± SD, median and data that were
not normally distributed were expressed as
median and interquartile range respectively.
Continuous variables were compared by t-test
for parametric variables (and Mann-Whithney
for non-parametric variables) and chi-squared
test was used to compare categorical variables.
The incidence density of CHD events with 95%
confidence interval (95% CI) were determined
by gender, and expressed in terms of per 1000
person-year. Subjects who did not participate
in follow up were excluded from incidence
calculations.
Multiple logistic regression model was
performed in order to assess the association
of some demographic, anthropometric and
biochemical characteristic with CHD event. For
determining the final model, using univariate
analysis, the association of each of the abovementioned variables with CHD was assessed
and then variables with P-value <0.2517 were
entered into the final model. Prediction model
for incident of CHD were appraised using
information of MASHAD prospective study.
Predictivity of incident CHD was estimated by
using the area under ROC curves, resulting from
adding some demographic and biochemical
risk factors especially traditional risk factors.
Evaluation of goodness-of-fit was done
using receiver operating characteristic
(ROC) analysis by comparing the predicted
probabilities calculated based on the multiple
logistic regression model with the observed
CHD: discriminative power of the model as a
measure of model performance is assessed by
the C-stat. The level of statistical significance
was p<0.05.

Results
Univariate and Multivariate analysis
There were significant differences in some
baseline characteristics as showed in Table 1,
including age, body mass index (BMI), waist
and hip circumference, diastolic blood pressure,
TGs, TC, HDL-C, LDL-C, Hs-CRP, smoking
habit, and the presence of hypertension
between men and women (p<0.001). There
was no significant difference in FBG and CHD
between the two sexes (p= 0.064 and p=0.48
respectively).
The findings differed using univariate and
multiple models. According to univariate
regression, age, systolic blood pressure (SBP),
waist to hip ratio (WHR), FBG, TG (p<0.001),
BMI (p=0.001), HDL-C (p=0.002) and LDL-C
levels (0.021) were associated with CHD.
However, after multiple logistic regression
these associations were not significant except
for age, SBP, FBG (p<0.001), BMI (p=0.033),
HDL-C (p=0.006) and smoking status
(p=0.050). The final model and evaluation of
goodness-of-fit with ROC analysis was then
accomplished.
ROC analysis
As shown in Figure 1, the area under ROC curve,
based on multiple logistic regression model of
CHD outcome, was 0.7825. Generally, ROC
analysis and the area under the curve (AUC)
indicates that this final model was able to
predict approximately 78% of CHD events in
this population.
Incidence density of CHD events
Our study showed that, 2.69% (n=235) CHD
cases were confirmed in MASHAD study
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Table 1. Baseline characteristics of 9818 men and women and total population.
Variable

Male (3878)

Female (5826)

p value

Total (n = 9704)

age (year)
48.83±8.43
47.55±8.09
<0.001
48.07±8.25
BMI (kg/m2)
26.35±4.14
28.92±4.83
<0.001
27.89±4.74
Waist circumference (cm)
93.68±11.03
96.24±12.55
<0.001
95.22±12.04
Hip circumference (cm)
101.06±7.95
105.50±9.75
<0.001
103.72±18.52
Systolic blood pressure (mm Hg)
122.35±17.15
121.49±20.29
0.025
121.80±18.52
Diastolic blood pressure (mm Hg)
80.04±10.64
78.56±12.45
<0.001
79.11±1.24
Triglycerides (mg/dl)
124(86-179)a
117(83-167)a
<0.001
120(85-172)a
Cholesterol (mg/dl)
186.79±37.81
194.36±39.72
<0.001
191.35±39.14
HDL-C (mg/dl)
39.84±9.25
44.87±9.89
<0.001
42.86±9.94
LDL-C (mg/dl)
113.50±34.49
118.53±35.68
<0.001
116.52±35.30
FBG (mg/dl)
91.74±37.37
93.22±40.38
0.064
92.70±39.32
Hs-CRP (mg/dl)
1.42 (0.90-2.90)a 1.82 (1.06-3.90)a
<0.001
1.63(0.99-3.53)a
Smoking, %
Never
57.3%
76.0%
<0.001
68.5%
Past
15.3%
6.3%
9.9%
Current
27.4%
17.6%
21.6%
Diabetes, %
13.7%
14.7%
0.167
14.4%
Hypertension, %
29.7%
32.8%
0.001
31.6%
Coronary heart disease%
3%
2.4%
0.48
2.7%
BMI, Body mass index; FBG, Fasting blood glucose; LDL-C, low-density lipoprotein cholesterol; HDL-C, High-density
lipoprotein cholesterol; Hs-CRP, High sensitivity C-reactive protein
aMedian (interquartile range) because of skewed distribution.
Table 2. Incidence density of CHD events in men in 100000 person- year with 95% confidence interval
N (%)
Crude
Age adjusted
SAP
24 (0.66)
667 (427-993)
240 (140-340)
UAP
57 (1.58)
1585 (1201-2054)
1380 (280-2480)
MI
18 (0.50)
500 (296-791)
180 (100-270)
SCD
11 (0.31)
306 (152-547)
110 (50-180)
Total
110 (3.01)
3060 (2515-3688)
1920 (810-3030)
SAP, Stable angina pectoris; UAP, Unstable angina pectoris; MI, myocardial infarction; SCD, Sudden cardiac death;
CHD, Coronary heart disease.
Table 3. Incidence density of CHD events in women in 100000 person- year with 95% confidence interval
Crude
Age adjusted
Stable Angina
39 (0.76)
762 (542-1042)
490 (80-900)
UAP
61 (1.19)
1193 (912-1532)
480 (360-600)
MI
9 (0.17)
176 (80-334)
70 (20-110)
SCD
16 (0.31)
312 (178-508)
120 (60-180)
Total
125 (2.42)
2444 (2034-2912)
1160 (730-1590)
SAP, Stable angina pectoris; UAP, Unstable angina pectoris; MI, myocardial infarction; SCD, Sudden cardiac death;
CHD, Coronary heart disease.
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Table 4. Associated factors with CHD outcome among study participants using logistic regression model
Predictors

Univariable

Multivariable

OR

(95% CI)

P value

OR

(95% CI)

P value

Age

1.102

1.085-1.119

<0.001

1.078

1.062- 1.095

<0.001

Sex

0.782

0.592-1.033

0.081

0.903

0.681-1.197

0.462

SBP (mmHg)
BMI (kg/m2)
WHR

1.029
1.049
1.515

1.023-1.036
1.027-1.072
1.250-1.836

<0.001
0.001
<0.001

1.015
1.031
1.129

1.008-1.023
1.002-1.061
0.913-1.397

<0.001
0.033
0. 245

FBG (mg/dL)
1.009
1.008-1.011
<0.001
1.007
1.006-1.009
<0.001
Triglyceride (mg/dL)
1.002
1.001-1.003
<0.001
1.000
0.999-1.001
0. 715
HDL-C (mg/dL)
0.970
0.953-0.987
0.002
0.969
0.949-0.990
0. 006
LDL-C (mg/dL)
1.004
1.000-1.009
0.021
1.003
0.998-1.007
0. 146
Smoking status
1.153
0.988-1.346
0.067
1.170
1.001-1.370
0. 050
Educational level
0.738
0.483-1.128
0.152
0.905
0.778-1.054
0. 190
SBP systolic blood pressure, BMI body mass index, WHR waist to hip ratio, FBG fasting blood glucose, HDL-C highdensity lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol

Figure 1. Receiver operating characteristic curves for prediction of CHD in MASHAD cohort study based on multiple
logistic regression model.

population. In the six years' follow-up of
Mashhad study, the incidence density of all
CHD event in men and women in 1000 personyear with 95% confidence intervals were
19.20 (8.10-30.30) and 11.60 (7.30-15.90),
respectively. The age adjusted incidence
of stable angina pectoris, unstable angina

pectoris, myocardial infarction, sudden
cardiac death in men in 1000 person-year with
95% CI were 2.40(1.40-3.40), 13.80(2.8024.80), 1.80(1.00-2.70) and 1.10(5.00-1.80)
respectively (table 2).
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Discussion
Coronary heart disease (CHD) is the cause of
13.3% of all death worldwide; it remains among
the leading causes of death and disability in
developed countries, and accounts for one third
of deaths above age 35 in western countries.18-20
The rate of CHD is increasing in Iran21 and in
the Middle East and Latin America.19
The results of the present study show that the
age-adjusted incidence density of CHD was
19.20 (8.10-30.30) and 11.60 (15.90-7.30)
per 1000 person-year, in men and women,
respectively during the six-year follow-up
study. Several studies in America have shown
that the incident rate of CHD is lower than those
reported in our study.22 Given the significant
statistical difference in many of anthropometric
and biochemical characteristics of men and
women in the Mashhad study including age,
diastolic blood pressure, body mass index,
waist circumference, hip circumference, serum
triglycerides, total cholesterol, HDL-C, LDL-C,
hs-CRP, positive smoking habit (P<0.001) and
systolic blood pressure (P=0.001), the incidence
density of CHD in Mashhad was compared
in men to women but it was not significantly
different (P=0.48).
In a study carried out in England, sex- and ageadjusted incidence rate of CHD in 2012-2016
and its risk factors have been reported to be
221 (225-218) per 100,000 person-year with
95% confidence level which is much lower
than those observed in Mashhad study, and
thus it is statistically considered a significant
difference.22
Moreover, high blood pressure was associated
with the highest rate of incidence among CHD
risk factors in the mentioned follow-up study
in England. In Japan, the incidence rate of
fatal coronary heart disease in 1996-2003 has

been reported to be 120 and 80 in men and
women, respectively per 100,000 person-year
which indicates the higher rate of incidence in
women compared to men. Findings indicate
higher incidence density of CHD in Mashhad
compared to Japan.23
Studies carried out in neighboring countries
such as Pakistan, Turkey, Afghanistan, and Iraq
have estimated the prevalence of CHD in these
regions, and there is no study determining the
incidence rate. According to the information
provided by World Health Organization (WHO),
the prevalence of death due to CHD has been
high in these countries. The proportion of death
due to CHD in Turkey, Saudi Arabia, Pakistan,
and Iran in 2016 has been 34, 37, 29, and 43
percent, respectively. CHD account for 60, 45,
and 43 percent of total deaths in Lebanon, Syria
and Jordon, an Egypt, respectively.24
In a follow-up study of blood glucose and
lipids in Tehran between 1999 -2010, agestandardized incidence rate of CHD based on
Iranian population has been 1050 (930-1160)
and 610 (530-690) per 100,000 person-year
for men and women, respectively with 95%
confidence level. There was no statistical
difference between Tehran and Mashhad in
CHD rate of incidence in men; while incidence
density in women was significantly higher in
Mashhad study. High incidence of coronary
diseases among women population in Iran may
be the result of the high prevalence of metabolic
syndrome in women compared to men (40.8%
vs. 27.9% and P<0.001). In addition, physical
activity level is lower and hence obesity is
more common among women. In a cohort
study carried out in Isfahan, age-adjusted
rate of incidence of CHD has been estimated
to be 1168 (1341-996) and 887 (738-1037)
per 100,000 person-year in men and women,
respectively with 95% confidence level.
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However, there was no statistical difference in
rate of incidence between Mashhad and Isfahan
populations.12
In the present study, the incidence density
of CHD had been determined in a six-year
follow-up, it was found that CHD risk factors
including age, waist circumference, blood
pressure, FBG, cholesterol, uric acid, TG, hsCRP, smoking, BMI, and LDL-C in patients
with CHD were higher compared to those not
reporting CHD. In addition, physical activity
level and HDL-C concentration was lower in
patients with CHD compared to those without.
These results are consistent with those found in
previous studies.13
The use of predictive models is increasing
day by day in medicine and cardiology.25 In
our study ROC analysis and the AUC value
of 78% indicates that our model has good
discriminatory power. Voss et al assessed
prediction of CHD in men population of
PROCAM study using logistic regression,
8.4% of participants were categorized as high
risk, which contained 45.8% of all CHD seen.26
Youlian et al conducted to predict CHD risk
by assessing different CHD risk factors in two
cohort populations including white and black
races. They found The AUC were 0.77 for
white men and 0.84 for white women as well
as 0.76 and 0.82 for black men and women,
respectively,27 which is in agreement with our
study.
Increased rates of CHD incidence and
prevalence in developing countries is likely
to be the result of changes in lifestyle,
urbanization, high consumption of processed
foods and foods with saturated fat, low fruits
and vegetables intake, and low micronutrients
intake in Iranian eating style, low levels of
physical activity along with high prevalence of
obesity and diabetes type 2.

Conclusion
The results of the present study indicate that the
incidence density of coronary heart diseases in
MASHAD cohort study increases with age. As
well as our final model designed in our study,
was able to predict approximately 78% of CHD
events in Iranian population.
Study limitations
These findings need to be tested over a longer
time period for CHD follow up and other
populations that have different environmental
and genetic backgrounds, so that stratified data
can be obtained by gender and socioeconomic
group.
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